Florian Leitsbach

QPLIX GmbH, provider of a leading software platform for the digital management of complex assets, on the minority investment by Partech Partners.
Shurgard, the largest developer, owner, and operator of self-storage facilities in Europe, on its acquisition of Pickens, a leading provider of self-storage space in northern Germany. This deal represents one of the largest self-storage transactions in the European market in 2023.
Crown Holdings, Inc., one of the world's leading suppliers of rigid packaging products to consumer marketing companies, as well as transit and protective packaging products, on the acquisition of Helvetia Packaging AG, a beverage can and end manufacturing facility in Germany.
Oliver Healthcare Packaging, a leading supplier of sterile barrier flexible packaging solutions for the global healthcare market, on the successful acquisition of EK-Pack Folien GmbH, a manufacturer of high-quality film and foil technology.
IntegrityNext and its shareholders on the €100 million investment of EQT Growth.
Friedemann Findeis and Klaus Rader as the sole shareholders of FR L'Osteria SE, a leading German and Austrian restaurant brand, on the sale of a majority stake to McWin. The transaction values L’Osteria at approximately USD 430 million.
Resolve BioSciences on its US$71 Million Series B Financing Round.
Ambienta on the sale of SF-Filter to funds advised by Equistone Partners.
ARTUS group, a portfolio company of Castik Capital, on the acquisition of Hestia.
Castik Capital on its acquisition of Artus group.
Special Situations Venture Partners III (SSVP III) on its sale of nox NachtExpress to Groupe Sterne, a portfolio company of Tikehau Capital.
gridX GmbH, a leading smart grid company, on the sale of a majority stake to energy group E.ON.
&ever GmbH on its €130 million sale to Kalera AS, forming a global leader in vertical farming.
Crown Holdings, Inc. in the sale of its European tinplate business to KPS Capital Partners, LP.
EyeEm Group, a leading AI powered global marketplace for premium stock photography and professional photo and video productions, on the sale of 100% of its shares to New Value AG; as well as previously on various financing rounds, and a cross-border merger.
Safran Corporate Ventures and STAR Capital on their investment in SkyFive AG, a leading provider of high-speed broadband In-Flight Connectivity (IFC) services, as part of the company’s Series A investment round.
OneFootball GmbH on its acquisition of Dugout, a digital media company co-owned by 10 of the world’s biggest football clubs.
Resolve Biosciences GmbH, a German molecular cartography firm, in its US$24 million Series A financing round.
VIA optronics AG, a leading supplier of enhanced display solutions, in its US$93.75 million cross-border initial public offering and listing on the NYSE.
Barings BDC, a publicly traded investment company, in the merger with MVC Capital, an externally-managed business development company trading on the New York Stock Exchange. The combined company is expected to have more than US$1.2 billion of investments on a pro forma basis.
MiddleGround Capital on its acquisition of a majority ownership in Dura Automotive Systems from Bardin Hill Investment Partners.
Arkema, a French chemicals group, in connection with its project to acquire Fixatti, a Swiss-Belgian group that specializes in producing high-performance thermobonding adhesive powders.
Shurgard Self Storage SA, the largest developer, owner and operator of self‐storage centers in Europe, on its acquisition of four ZeitLager facilities in Germany.
Berwind Group on its acquisition of German industrial companies Mess-und Schnellanschluss-Systeme GmbH and innomatec Test- und Sonderanlagen GmbH.
American Express Global Business Travel (GBT) on its acquisition of DER Business Travel, part of REWE Group owned Touristik Central Europe.
Laboratoire HRA Pharma, a portfolio company jointly backed by Astrog Partners and Goldman Sachs Merchant Banking Division, on its acquisition of the global rights to the Mederma brand from Germany-based Merz Pharmaceuticals GmbH.
One Equity Partners on its sale of PeroxyChem to Evonik Industries for US$640 million.